ClinicalTrials.govpublic full text
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell
graft-vs-host disease (gvhd), mesenchymal stem cell (msc), allogeneic hematopoietic stem cell transplant, allotransplant, allogenic, refractory, csm/eich2005, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.